Effect of different SARS-CoV-2 variants on COVID 19 assays and vaccines

June 29, 2021

SARS-CoV-2, the causative agent of COVID-19, has an ssRNA genome of almost 30kb that encodes for a total of 26 proteins. Among the four structural viral protein, in particular the S protein stands out. The S protein protrudes from the spherical virion and gives it its characteristic appearance. It is also crucial for the virus’ interaction with its host cells. Furthermore, the S protein is the main target for most SARS-CoV-2 vaccines. As such, mutations in this protein can severely impact the efficacy of SARS-CoV-2 vaccines.

In this webinar, Dr. Stefan Pellenz Product Manager from Antibodies online and Dr. Andreas Langer, R&D Scientist at NanoTemper Technologies, will review known SARS-CoV-2 S protein mutations, discuss their potential effect on antibody binding, and illustrate this effect on a well characterized anti-S protein antibody.

Learn more about the references mentioned in this webinar.

Previous Article
Capsid lattice destabilization leads to premature loss of the viral genome and integrase enzyme during HIV-1 infection
Capsid lattice destabilization leads to premature loss of the viral genome and integrase enzyme during HIV-1 infection

Up next
Measuring multivalent interactions: uncovering the secrets of virus binding strategies
Measuring multivalent interactions: uncovering the secrets of virus binding strategies

Influenza A virus (IAV) utilizes a multivalent binding strategy to the host cell, binding its trimeric spik...

Challenged by the complexity of
virus biology?

Biophysical methods can help.

Find out how